Jessica Flechtner

Jessica Flechtner

Company: Genocea

Job title: CSO


The Impact of Stimulatory & Inhibitory Neoantigens Selected with the ATLAS Bioassay: Clinical & Pre-Clinical Results 9:10 am

• ATLAS identifies stimulatory and inhibitory CD4+ and CD8+ T cell responses to neoantigens and common antigens • Preclinical models show the deleterious impact of inhibitory T cell responses on anti-tumor immunity • Be careful, common neoantigens may differ from common mutations • The GEN-009 immunotherapy, designed with personalised ATLAS-identified stimulatory neoantigens has resulted in…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.